These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 7669168

  • 1. Synthesis and adrenergic beta-blocking activity of ortho-, meta- and para-oxypropanolamino-substituted [(benzylideneamino)oxy]propanolamines.
    Balsamo A, Lapucci A, Macchia B, Macchia M, Orlandini E, Rossello A, Ferni G, Pinza M.
    Farmaco; 1995 Apr; 50(4):239-43. PubMed ID: 7669168
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and beta-adrenergic antagonist activity of novel (3-oxazolinyl-1,4-dihydropyridyl) propanolamines.
    Vo D, Wolowyk MW, Knaus EE.
    Drug Des Discov; 1992 Jul; 8(4):265-72. PubMed ID: 1359908
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and beta-adrenergic activity of a series of 3-(substituted-benzylideneaminoxy)propanolamine derivatives.
    Gentili D, Lapucci A, Macchia B, Macchia M, Martinelli A, Nencetti S, Orlandini E, Ferni G, Pinza M.
    Farmaco; 1995 Jul; 50(7-8):519-26. PubMed ID: 7669190
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and beta-adrenergic activity of new completely aliphatic 3-(methyleneaminoxy)propanolamine derivatives.
    Balsamo A, Gentili D, Lapucci A, Macchia M, Martinelli A, Orlandini E, Ferni G, Pinza M.
    Farmaco; 1994 Dec; 49(12):759-66. PubMed ID: 7893332
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and beta-adrenergic antagonist activity of novel (3-cyanodihydropyridyl)propanolamines.
    Vo D, Wolowyk MW, Knaus EE.
    Drug Des Discov; 1991 Dec; 8(2):157-64. PubMed ID: 1686561
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and cardioselective beta-adrenergic antagonist activity of quinolyloxypropanolamines.
    Vo D, Wolowyk MW, Knaus EE.
    Drug Des Discov; 1992 Dec; 9(1):69-78. PubMed ID: 1360842
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological properties of new 1,2-benzisothiazolyloxypropanolamines on cardiac and tracheal beta-receptors.
    Barocelli E, Chiavarini M, Ballabeni V, Mingiardi MR, Morini G, Ronchini F, Impicciatore M.
    Boll Soc Ital Biol Sper; 1992 Jul; 68(7):445-51. PubMed ID: 1362354
    [Abstract] [Full Text] [Related]

  • 8. Derivatives related to betaxolol with alpha- and beta-adrenergic activities.
    Leclerc G, Decker N, Schwartz J.
    Arzneimittelforschung; 1985 Jul; 35(9):1357-67. PubMed ID: 2867769
    [Abstract] [Full Text] [Related]

  • 9. [Beta-1 and beta-2 blocking activities of a new series of (arylalkoxy) propanolamines].
    Rosell G, Mauleón D, Pujol MD, Granados R.
    Arch Farmacol Toxicol; 1986 Apr; 12(1):65-70. PubMed ID: 2874776
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
    Mokrý P, Zemanová M, Csöllei J, Racanská E, Tumová I.
    Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
    [Abstract] [Full Text] [Related]

  • 11. A structure activity relationship study on 1-isopropylamino-3-(2'-substituted naphthoxy)-propan-2-ois analogs.
    Srivastava AK, Mishra N, Khan AA, Gupta DK.
    Res Commun Mol Pathol Pharmacol; 1994 Sep; 85(3):351-4. PubMed ID: 7827810
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and beta-adrenergic antagonist activity of heterocyclic propanolamines.
    Vo D, Wolowyk MW, Knaus EE.
    Drug Des Discov; 1993 Jun; 10(2):89-99. PubMed ID: 8104518
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (II).
    Khouili M, Guillaumet G, Coudert G, Pujol MD.
    Farmaco; 1996 Mar; 51(3):185-8. PubMed ID: 8688140
    [Abstract] [Full Text] [Related]

  • 14. beta-Adrenergic blocking agents. alpha- and gamma-methyl(aryloxy)propanolamines.
    Lemke TL, Cramer MB, Adamski SW, Pedone CA, Brooker G.
    J Med Chem; 1981 Oct; 24(10):1211-4. PubMed ID: 6120233
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (I).
    Khouili M, Guillaumet G, Coudert G, Pujol MD.
    Farmaco; 1996 Mar; 51(3):175-84. PubMed ID: 8688139
    [Abstract] [Full Text] [Related]

  • 16. beta 1-selective adrenoceptor antagonists. 1. Synthesis and beta-adrenergic blocking activity of a series of binary (aryloxy)propanolamines.
    Kierstead RW, Faraone A, Mennona F, Mullin J, Guthrie RW, Crowley H, Simko B, Blaber LC.
    J Med Chem; 1983 Nov; 26(11):1561-9. PubMed ID: 6138434
    [Abstract] [Full Text] [Related]

  • 17. Cardioselectivity as a function of molecular structure in beta-adrenoceptor blocking agents of the 1-(para-substituted aryloxy)-3-(isopropylamino)propan-2-ol type.
    Erez M, Shtacher G, Weinstock M.
    J Med Chem; 1978 Sep; 21(9):982-4. PubMed ID: 31488
    [Abstract] [Full Text] [Related]

  • 18. The [(methyloxy)imino]methyl moiety as a bioisoster of aryl. A novel class of completely aliphatic beta-adrenergic receptor antagonists.
    Macchia B, Balsamo A, Breschi MC, Chiellini G, Macchia M, Martinelli A, Martini C, Nardini C, Nencetti S, Rossello A.
    J Med Chem; 1994 May 13; 37(10):1518-25. PubMed ID: 7910217
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modeling, design, chiral aspects and role of para-substituents in aryloxypropranolamine based beta-blockers.
    Nandel FS, Dhaliwal RK, Singh B.
    Indian J Biochem Biophys; 1999 Feb 13; 36(1):29-35. PubMed ID: 10549157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.